<!doctype html><html lang=cn><head><meta charset=utf-8><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=viewport content="width=device-width,initial-scale=1"><meta name=referrer content="no-referrer"><link rel=dns-prefetch href=https://i.geekbank.cf/><title>渐冻症新药！正大丰海「依达拉奉氯化钠注射液」新适应症获批 | 极客快訊</title><meta property="og:title" content="渐冻症新药！正大丰海「依达拉奉氯化钠注射液」新适应症获批 - 极客快訊"><meta property="og:type" content="article"><meta property="og:locale" content="cn"><meta property="og:image" content="https://p1.pstatp.com/large/pgc-image/88bd947a84134cebbd2b46af642478ad"><link rel=alternate hreflang=x-default href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%a6/4041a94.html><link rel=alternate hreflang=zh-tw href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%a6/4041a94.html><link rel=alternate hreflang=zh-cn href=https://geekbank.cf/cn/%e7%a7%91%e5%ad%a6/4041a94.html><link rel=alternate hreflang=zh-hk href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%a6/4041a94.html><link rel=alternate hreflang=zh-mo href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%a6/4041a94.html><link rel=alternate hreflang=zh-my href=https://geekbank.cf/cn/%e7%a7%91%e5%ad%a6/4041a94.html><link rel=alternate hreflang=zh-sg href=https://geekbank.cf/cn/%e7%a7%91%e5%ad%a6/4041a94.html><link rel=canonical href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%a6/4041a94.html><meta property="article:published_time" content="2020-10-29T21:02:17+08:00"><meta property="article:modified_time" content="2020-10-29T21:02:17+08:00"><meta name=Keywords content><meta name=description content="渐冻症新药！正大丰海「依达拉奉氯化钠注射液」新适应症获批"><meta name=author content="极客快訊"><meta property="og:url" content="/cn/%E7%A7%91%E5%AD%A6/4041a94.html"><link rel=apple-touch-icon sizes=180x180 href=../../apple-touch-icon.png><link rel=icon type=image/png sizes=32x32 href=../../favicon-32x32.png><link rel=icon type=image/png sizes=16x16 href=../../favicon-16x16.png><link rel=manifest href=../../site.webmanifest><link rel=mask-icon href=../../safari-pinned-tab.svg color=#5bbad5><meta name=msapplication-TileColor content="#ffc40d"><meta name=theme-color content="#ffffff"><link rel=stylesheet href=https://geekbank.cf/css/normalize.css><link rel=stylesheet href=https://geekbank.cf/css/style.css><script type=text/javascript src=https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js></script><script type=text/javascript src=https://geekbank.cf/js/jqthumb.min.js></script><script data-ad-client=ca-pub-3525055026201463 async src=https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js></script></head><body><header id=header class=clearfix><div class=container><div class=col-group><div class=site-name><h1><a id=logo href>🤓 极客快讯 Geek Bank</a></h1><p class=description>为你带来最全的科技知识 🧡</p></div><div><nav id=nav-menu class=clearfix><a class=current href>猜你喜歡</a>
<a href=../../tw/categories/%E7%A7%91%E6%8A%80.html title=科技>科技</a>
<a href=../../tw/categories/%E9%81%8A%E6%88%B2.html title=遊戲>遊戲</a>
<a href=../../tw/categories/%E7%A7%91%E5%AD%B8.html title=科學>科學</a></nav></div></div></div></header><div id=body><div class=container><div class=col-group><div class=col-8 id=main><div class=res-cons><article class=post><header><h1 class=post-title>渐冻症新药！正大丰海「依达拉奉氯化钠注射液」新适应症获批</h1></header><date class="post-meta meta-date">2020-10-29</date><div class=post-meta><span>|</span>
<span class=meta-category><a href=cn/categories/%E7%A7%91%E5%AD%A6.html>科学</a></span></div><div class=post-content><div class=pgc-img><img alt=渐冻症新药！正大丰海「依达拉奉氯化钠注射液」新适应症获批 onerror=errorimg.call(this); src=https://p1.pstatp.com/large/pgc-image/88bd947a84134cebbd2b46af642478ad><p class=pgc-img-caption></p></div><p><br>5月19日，正大丰海国内首仿依达拉奉氯化钠注射液（商品名：依必坦）用于治疗肌萎缩侧索硬化（ALS）的新适应症获得国家药监局批准。依必坦成为国内唯一同时拥有脑梗塞和ALS两大适应症的依达拉奉制剂。</p><div class=pgc-img><img alt=渐冻症新药！正大丰海「依达拉奉氯化钠注射液」新适应症获批 onerror=errorimg.call(this); src=https://p1.pstatp.com/large/pgc-image/f526ac3ad9b1426ba9be301fc6d27611><p class=pgc-img-caption></p></div><p>ALS（肌萎缩侧索硬化症，俗称“渐冻症”）是罕见病的一种，随着病程的发展，患者会变得肌肉无力，甚至瘫痪，并在出现首次症状的3~5年内发生呼吸衰竭而亡。据美国疾病控制和预防中心估计，大约有12000-15000的美国人患有该病。据推测，中国有近20万患者饱受折磨。<br>在ALS药物方面，利鲁唑是FDA于1995年12月批准的第一款治疗ALS的药物。Radicava （edaravone ，依达拉奉静脉注射液）是22年来FDA唯一批准用于治疗ALS的药物。依必坦是一种自由基清除剂，被认为能够缓解氧化应激的影响，而这可能是ALS发病和病情发展的关键因素。其抗氧化作用被认为能够为神经系统提供神经保护性支持，潜在延缓疾病发展或限制额外伤害。</p><div class=pgc-img><img alt=渐冻症新药！正大丰海「依达拉奉氯化钠注射液」新适应症获批 onerror=errorimg.call(this); src=https://p1.pstatp.com/large/pgc-image/808097ee797b49da947dae9b4da09bb8><p class=pgc-img-caption></p></div><p>点亮“在看”，好文相伴</p><div class=pgc-img><img alt=渐冻症新药！正大丰海「依达拉奉氯化钠注射液」新适应症获批 onerror=errorimg.call(this); src=https://p1.pstatp.com/large/pgc-image/9ffd04fd6bf64e8fa1a45f7683804976><p class=pgc-img-caption></p></div></div><div class="post-meta meta-tags"><ul class=clearfix><li><a>'渐冻症','新药','丰海'</a></li></ul></div></article></div></div><div id=secondary><section class=widget><form id=search action=//www.google.com/search method=get accept-charset=utf-8 target=_blank _lpchecked=1><input type=text name=q maxlength=20 placeholder=搜索>
<input type=hidden name=sitesearch value=geekbank.cf>
<button type=submit>🔍</button></form></section><section class=widget><h3 class=widget-title>最新文章 ⚡</h3><ul class=widget-list></ul></section><section class=widget><h3 class=widget-title>其他</h3><ul class=widget-list><li><a href=TOS.html>使用條款</a></li><li><a href=CommentPolicy.html>留言政策</a></li><li><a href=mailto:gdnews@tuta.io rel=nofollow>DMCA</a></li><li><a href=mailto:gdnews@tuta.io rel=nofollow>聯絡我們</a></li></ul></section></div></div></div></div><footer id=footer><div class=container>&copy; 2020 <a href>极客快訊</a></div></footer><script type=text/javascript>window.MathJax={tex2jax:{inlineMath:[['$','$']],processEscapes:true}};</script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-MML-AM_CHTML" async></script><a id=rocket href=#top></a><script type=text/javascript src=https://kknews.cf/js/totop.js async></script><script type=application/javascript>var doNotTrack=false;if(!doNotTrack){window.ga=window.ga||function(){(ga.q=ga.q||[]).push(arguments)};ga.l=+new Date;ga('create','UA-146415161-2','auto');ga('send','pageview');}</script><script async src=https://www.google-analytics.com/analytics.js></script><script type=text/javascript src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-5e508ed9e4e698bb"></script></body></html>